🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

London's FTSE 100 set for worst week since October on lockdown worries

Published 29/01/2021, 09:18
© Reuters.
UK100
-
AZN
-
FTMC
-
FTNMX551030
-
FTNMX601010
-
BOOH
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* FTSE 100 down 1.7%, FTSE 250 off 1.3%

Jan 29 (Reuters) - The FTSE 100 dropped on Friday and was
set to record its worst week since October as stalled vaccine
rollouts and lockdowns to curb the spread of contagious new
coronavirus strains kept investors from jumping into riskier
assets.
The blue-chip FTSE 100 index .FTSE dropped 1.7%, with
energy .FTNMX0530 and mining .FTNMX1770 stocks being top
drags for the week, while the mid-cap index .FTMC fell 1.3%.
The benchmark indices were also set to fall for the month,
with the mid-cap index set to record its worst monthly loss
since September.
Drugmaker AstraZeneca AZN.L fell 3.6% for the week and was
one of the top drags on the blue-chip index as a tussle with the
European Union on vaccine rollouts continued to weigh on the
stock.
The European Union's contract with AstraZeneca for its
COVID-19 vaccine contains binding orders, EU Commision Head
Ursula von der Leyen said, demanding a plausible explanation
from the drugmaker for delivery hold-ups. British online fashion retailer Boohoo BOOH.L fell 1.5%
after it confirmed on Friday it was in exclusive talks with the
administrators of Philip Green's collapsed Arcadia group over
the purchase of the Dorothy Perkins, Wallis and Burton
brands.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.